Departament d'Enginyeria Química, Centre de Biotecnologia Molecular, Universitat Politècnica de Catalunya, Terrassa, Spain.
FEBS J. 2011 May;278(9):1493-505. doi: 10.1111/j.1742-4658.2011.08066.x. Epub 2011 Mar 15.
The visual photoreceptor rhodopsin undergoes a series of conformational changes upon light activation, eventually leading to the active metarhodopsin II conformation, which is able to bind and activate the G-protein, transducin. We have previously shown that mutant rhodopsins G51V and G89D, associated with retinitis pigmentosa, present photobleaching patterns characterized by the formation of altered photointermediates whose nature remained obscure. Our current detailed UV-visible spectroscopic analysis, together with functional characterization, indicate that these mutations influence the relative stability of the different metarhodopsin photointermediates by altering their equilibria and maintaining the receptor in a nonfunctional light-induced conformation that may be toxic to photoreceptor cells. We propose that G51V and G89D shift the equilibrium from metarhodopsin I towards an intermediate, recently named as metarhodopsin Ib, proposed to interact with transducin without activating it. This may be one of the causes contributing to the molecular mechanisms underlying cell death associated with some retinitis pigmentosa mutations.
视觉光感受器视紫红质在光激活时经历一系列构象变化,最终导致活性视紫红质 II 构象,其能够结合并激活 G 蛋白转导蛋白。我们之前已经表明,与色素性视网膜炎相关的突变视紫红质 G51V 和 G89D 呈现出光漂白模式,其特征是形成了性质仍不清楚的改变的光中间产物。我们目前的详细紫外可见光谱分析以及功能表征表明,这些突变通过改变它们的平衡并使受体保持在可能对光感受器细胞有毒的非功能性光诱导构象中来影响不同视紫红质后中间产物的相对稳定性。我们提出 G51V 和 G89D 将平衡从视紫红质 I 向最近命名为视紫红质 Ib 的中间产物转移,该中间产物据推测与转导蛋白相互作用而不激活它。这可能是导致某些色素性视网膜炎突变相关细胞死亡的分子机制的原因之一。